ChainCatcher news, according to TechCrunch, NewLimit, co-founded by Coinbase CEO Brian Armstrong, has completed a $130 million Series B funding round, led by Kleiner Perkins, with participation from Nat Friedman, Daniel Gross, Khosla Ventures, Founders Fund, Dimension Capital, Elad Gil, Garry Tan, Patrick Collison, and others.It is reported that the company mainly develops anti-aging therapies using artificial intelligence models and has currently identified three prototype drugs that can reprogram liver cells.